News and features

Articles

Article type
Jurisdiction
Practice area

Showing 1 - 10 of 114

News & Analysis

Switzerland: Bär & Karrer advises BNP Paribas on the sale of two investment properties

28 January 2026 by Bär & Karrer - Switzerland

Bär & Karrer legally advised BNP Paribas REIM, acting on behalf of one of its managed funds, on the successful sale of two investment properties in prime city locations in Basel and St. Gallen to two institutional investors.

News & Analysis

Switzerland: JCDecaux SE sells an additional stake in APG|SGA - Shareholders of APG|SGA approve the selective opting up clause

27 January 2026 by Bär & Karrer - Switzerland

JCDecaux SE (Euronext Paris: DEC), the number one outdoor advertising com- pany worldwide, announced on 12 December 2025 that a share purchase agreement was signed between JCDecaux SE and NZZ, under which JCDecaux SE will sell 325,519 APG|SGA's shares, corresponding to 10.85% of the share capital of APG|SGA.

News & Analysis

Switzerland: Bär & Karrer advises UBS on the completion of the sale of its stake in Swisscard and the transition of the Credit Suisse branded card portfolios

26 January 2026 by Bär & Karrer - Switzerland

On 21 January 2026, the successful completion of the sale of UBS Switzerland AG's ("UBS") 50% stake in Swisscard AECS GmbH ("Swisscard") to American Express Swiss Holdings GmbH was published in the Swiss Official Gazette of Commerce.

News & Analysis

Switzerland: Bär & Karrer advises team blue on its strategic investment in Windsor ai

22 January 2026 by Bär & Karrer - Switzerland

team.blue completed a strategic investment in Windsor Group AG, the operator of a leading Swiss AI-powered data integration and marketing attribution platform for businesses across Europe. team.blue becomes a strategic partner alongside the existing shareholders.

News & Analysis

Switzerland: Bär & Karrer advises Worthington Steel in acquisition of Kloeckner & Co

20 January 2026 by Bär & Karrer - Switzerland

Worthington Steel (NYSE: WS), a metals processor that partners with customers to deliver highly technical and customized solutions, entered into a Business Combination Agreement with Kloeckner & Co (XETR: KCO), a leading service center and metal processing company with facilities across North America and Europe.

News & Analysis

Switzerland: Nxera Pharma concludes License Agreement with and invests into Santhera Pharmaceuticals

13 January 2026 by Bär & Karrer - Switzerland

Nxera Pharma Co. Ltd, listed on the Tokio Stock Exchange, has entered into an exclusive licensing agreement with Santhera Pharmaceuticals under which Nxera will commercialize the drug AGAMREE® in Japan, South Korea, Australia and New Zealand. Concurrently, Nxera invests in SIX-listed Santhera Pharmaceuticals Holding AG.

News & Analysis

Switzerland: Bär & Karrer Advises the Ortlinghaus Group on the Sale of its EM+H Division

12 January 2026 by Bär & Karrer - Switzerland

In connection with a carve-out process, the Ortlinghaus Group sold its EM+H Division, which encompasses among others the production and sale of electromagnetic brakes and clutches as well as pneumatic toothed clutches and other trade goods to Stüwe Switzerland AG, a group company of Stüwe GmbH & Co. KG.

News & Analysis

Switzerland: Bär & Karrer Advises Allurity in its Acquisition of the Swiss Operational Technology Security Provider MSF Partners

07 January 2026 by Bär & Karrer - Switzerland

Allurity, a leading European group of cybersecurity service providers, acquired Monti Stampa Furrer & Partners Group (MSF Partners), an operational technology (OT) security firm specialized in safeguarding critical business assets and infrastructure including manufacturing plants, hydro dams, energy generation and mining facilities, and other essential systems that societies rely on. The transaction was closed on 31 October 2025.

News & Analysis

Switzerland: Bär & Karrer Advises Omnidocs Group (Main Capital Partners) on the Acquisition of officeatwork AG

23 December 2025 by Bär & Karrer - Switzerland

Omnidocs Group ApS (Denmark), a portfolio company of Main Capital Partners and a provider of document creation software, has acquired all shares in officeatwork AG. officeatwork AG is a provider of document creation solutions.

News & Analysis

Switzerland: Bär & Karrer Advises SK Capital LP on the Acquisition of Swixx BioPharma Holding AG

15 December 2025 by Bär & Karrer - Switzerland

The US private equity investor SK Capital LP has acquired the Swixx BioPharma Group. The Swixx BioPharma Group is a leading global full-service partner in the distribution of biopharmaceutical products, particularly in Central and Eastern Europe and Latin America.